We are excited to announce the publication of our latest research, "Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the 'MOZART' prospective observational study," in The Oncologist. The study highlights the clinical value of molecular profiling in metastatic solid tumors using comprehensive NGS-based panels to improve treatment algorithms in situations of uncertainty and facilitate clinical trial recruitment.
For more details, the full study is available here.